Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$633,827
+$35,018 QoQ
Shares Held
1,276
-4.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#999
of 1,742 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HANCOCK WHITNEY CORP holds $38,673,624 across 11 Biotechnology names. VRTX ranks #5 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
330,756 | $17,996,433 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
205,652 | $16,096,381 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
6,649 | $1,602,209 | |
| 4 | INCY |
Incyte Corp
|
10,836 | $1,228,368 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,276 | $633,827 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
792 | $493,843 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
8,677 | $315,928 | |
| 8 | INVA |
Innoviva, Inc.
|
11,967 | $271,769 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $633,827 | 1,276 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $598,809 | 1,341 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $601,155 | 1,326 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $524,405 | 1,339 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $606,362 | 1,362 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $651,113 | 1,343 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $614,922 | 1,527 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,259,436 | 2,708 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,306,322 | 2,787 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,167,083 | 2,792 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $1,094,940 | 2,691 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $968,108 | 2,784 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $968,104 | 2,751 | Shares | Sole | 2023-11-13 | |
| 2023-03-31 | $801,223 | 2,543 | Shares | Sole | 2023-11-13 | |
| 2022-12-31 | $525,002 | 1,818 | Shares | Sole | 2023-11-13 | |
| 2022-09-30 | $525,804 | 1,816 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $506,658 | 1,798 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $544,905 | 2,088 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $436,345 | 1,987 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $356,068 | 1,963 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $390,960 | 1,939 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $440,954 | 2,052 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $899,273 | 3,805 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,044,940 | 3,840 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $1,242,526 | 4,280 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $1,031,513 | 4,335 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||